| CASE REPORT |
|
| Ahead of Print |
|
|
Outcome of peripapillary polypoidal choroidal vasculopathy treatment using combination therapy intravitreal ranibizumab and thermal retinal laser photocoagulation
Ogugua Ndubuisi Okonkwo1, Toyin Akanbi2, Tolulope Odubela3, Martha-Mary Udoh4
1 Department of Ophthalmology, Eye Foundation Hospital, Lagos; Department of Ophthalmology, Eye Foundation Hospital, Abuja, Nigeria
2 Department of Ophthalmology, Eye Foundation Hospital, Abuja, Nigeria
3 Department of Ophthalmology, Eye Foundation Hospital, Lagos, Nigeria
4 Department of Ophthalmology, University of Calabar Teaching Hospital, Calabar, Nigeria
Correspondence Address:
Ogugua Ndubuisi Okonkwo,
Eye Foundation Retina Institute & Eye Foundation Hospital, 27 Isaac John Street, GRA. Ikeja, Lagos
Nigeria
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/aam.aam_68_22
|
|
|
We present the case of a middle-aged female Nigerian diagnosed to have right eye peripapillary polypoidal choroidal vasculopathy (PCV). At presentation, her right eye Snellen visual acuity was 6/24+ (unaided) and 6/12 (aided) and the left eye was 6/9 (unaided) and 6/6 (aided). Fundus fluorescein angiography showed a hyperfluorescent peripapillary subretinal lesion associated with subretinal fluid demonstrated on spectral-domain optical coherence tomography. The PCV lesion was successfully treated using a combination of 3 monthly doses of intravitreal ranibizumab initially, followed by one session of focal thermal retinal laser photocoagulation. Her clinical state has remained stable after 5 years of follow-up, requiring no further treatment. This case demonstrates the effectiveness of combination therapy and can be a strategy for treating this PCV type. Successful treatment using this approach will reduce the burden of intravitreal anti-vascular endothelial growth factor, e.g., ranibizumab injections.
|
|
|
|
|
|
|
Search Pubmed for